Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
eli lilly
genentech
2
×
investing
2
×
life sciences
national blog main
national top stories
roche
2
×
san francisco blog main
san francisco top stories
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
apalutamide
atypical hemolytic uremic syndrome
avapritinib
bill cassidy
biogen
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
caelum biosciences
cancer
cancer immunotherapy
celgene
chuck grassley
clinical trials
corvus pharmaceuticals
crenezumab
cstone pharmaceuticals
What
drug
alzheimer’s
approval
bio
blueprint
cancer
candidate
companies
currently
different
fail
fda
gene
increases
latest
marketing
medicines
muscle
pact
pharmaceutical
plan
prescription
price
prices
raise
regulatory
ret
review
roche
roundup
start
team
therapies
typically
wins
year
Language
unset
Current search:
genentech
×
roche
×
investing
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More